C
하나제약
293480KOSPI의약품 제조업45.0 / 100
Reference Date: 2026-04-13
Financial Score16.5 / 40
News Sentiment12.5 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but Operating Profit is on a declining trend. Roughly flat over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Hana Pharmaceutical specializes in the production and sale of specialty pharmaceuticals, with a strong presence in analgesics and anesthetics. The company offers a wide range of health insurance-listed drugs and operates manufacturing plants in Hwaseong, Gyeonggi, along with an R&D center in Pangyo.
Number of Employees
706people
Average Salary
53.0M KRW
Score Calculation Basis
Detailed Financial Score
PER
18.72Industry Average 14.803.0Point
Higher than industry avg (caution)
PBR
0.54Industry Average 1.045.5Point
Lower than industry avg (good)
ROE
2.82Industry Average 4.422.5Point
Below industry avg
Debt Ratio
12.95Industry Average 11.982.0Point
Higher than industry avg (caution)
Trend 2023~20253.5 / 10 points
Revenue Growth Rate
1.0 / 3
Avg ▲3.3% (2-year basis)
Operating Profit Growth Rate
0.5 / 3
Avg ▼2.2% (2-year basis)
ROE Trend
2.0 / 4
Avg ROE 6.1% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (11%, downtrend)
Current 9,490Won52-week high 12,43052-week low 9,090
1-month return3.0Point
1m 0% (flat)
Volume trend2.0Point
Volume decreasing
Detailed Disclosure
3 totalPositive 0Neutral 3Negative 0
- Neutral정기주주총회결과2026-03-30
- Neutral사업보고서 (2025.12)2026-03-20
- Neutral감사보고서제출2026-03-20